Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials I Garcia-Doval, G Carretero, F Vanaclocha, C Ferrandiz, E Daudén, ... Archives of dermatology 148 (4), 463-470, 2012 | 208 | 2012 |
Consensus document on the evaluation and treatment of moderate‐to‐severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology E Daudén, L Puig, C Ferrándiz, JL Sánchez‐Carazo, ... Journal of the European Academy of Dermatology and Venereology 30, 1-18, 2016 | 126 | 2016 |
Infections in moderate to severe psoriasis patients treated with biological drugs compared to classic systemic drugs: findings from the BIOBADADERM registry P Dávila-Seijo, E Dauden, MA Descalzo, G Carretero, JM Carrascosa, ... Journal of Investigative Dermatology 137 (2), 313-321, 2017 | 120 | 2017 |
Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry JM Carrascosa, M Vilavella, I Garcia‐Doval, G Carretero, F Vanaclocha, ... Journal of the European Academy of Dermatology and Venereology 28 (7), 907-914, 2014 | 90 | 2014 |
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the … G Carretero, C Ferrandiz, E Dauden, F Vanaclocha Sebastian, ... Journal of the European Academy of Dermatology and Venereology 29 (1), 156-163, 2015 | 73 | 2015 |
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry C Medina, G Carretero, C Ferrandiz, E Dauden, F Vanaclocha, ... Journal of the European Academy of Dermatology and Venereology 29 (5), 858-864, 2015 | 60 | 2015 |
Estudio bibliométrico de la revista Actas Dermo-Sifiliográficas (1984-2003) II. Análisis de las referencias bibliográficas J Miralles, JM Ramos, R Ballester, I Belinchón, A Sevila, M Moragón Actas Dermo-Sifiliográficas 96 (9), 563-571, 2005 | 59 | 2005 |
Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and … L Puig, JM Carrascosa, I Belinchón, V Fernández-Redondo, G Carretero, ... Actas Dermo-Sifiliográficas (English Edition) 104 (6), 488-496, 2013 | 57 | 2013 |
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases … E Daudén, G Carretero, R Rivera, C Ferrándiz, M Llamas-Velasco, ... Journal of the American Academy of Dermatology 83 (1), 139-150, 2020 | 56 | 2020 |
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: A study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in … AI Sánchez‐Moya, I García‐Doval, G Carretero, J Sánchez‐Carazo, ... Journal of the European Academy of Dermatology and Venereology 27 (11), 1366 …, 2013 | 55 | 2013 |
Severe skin reaction to imatinib in a case of Philadelphia-positive acute lymphoblastic leukemia B Sanchez-Gonzalez, JC Pascual-Ramirez, P Fernandez-Abellan, ... Blood, The Journal of the American Society of Hematology 101 (6), 2446-2446, 2003 | 54 | 2003 |
Epidemiology of leprosy in Spain: the role of the international migration JM Ramos, D Romero, I Belinchón PLoS neglected tropical diseases 10 (3), e0004321, 2016 | 52 | 2016 |
Gender differential on characteristics and outcome of leprosy patients admitted to a long-term care rural hospital in South-Eastern Ethiopia JM Ramos, M Martínez-Martín, F Reyes, D Lemma, I Belinchón, ... International Journal for Equity in Health 11, 1-7, 2012 | 50 | 2012 |
Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children A Tagarro, E Cobos-Carrascosa, S Villaverde, FJ Sanz-Santaeufemia, ... European journal of pediatrics, 1-11, 2022 | 45 | 2022 |
Evolution of cooperation patterns in psoriasis research: Co-authorship network analysis of papers in Medline (1942–2013) G González-Alcaide, J Park, C Huamani, I Belinchon, JM Ramos PloS one 10 (12), e0144837, 2015 | 43 | 2015 |
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective … I García‐Doval, MV Hernández, F Vanaclocha, A Sellas, P de la Cueva, ... British Journal of Dermatology 176 (3), 643-649, 2017 | 42 | 2017 |
Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: a cross-sectional study in clinical practice JM Carrascosa, I Garcia-Doval, B Pérez-Zafrilla, G Carretero, ... Journal of Dermatological Treatment 26 (6), 502-506, 2015 | 42 | 2015 |
Spanish adaptation of the European guidelines for the evaluation and treatment of actinic keratosis C Ferrándiz, E Fonseca-Capdevila, A García-Diez, C Guillén-Barona, ... Actas Dermo-Sifiliográficas (English Edition) 105 (4), 378-393, 2014 | 41 | 2014 |
[Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of … JM Carrascosa, L Puig, IB Romero, L Salgado-Boquete, E Del Alcázar, ... Actas dermo-sifiliograficas 113 (3), T261-T277, 2022 | 36 | 2022 |
Tinea capitis in schoolchildren in a rural area in southern E thiopia M Leiva‐Salinas, I Marin‐Cabanas, I Betlloch, A Tesfasmariam, F Reyes, ... International Journal of Dermatology 54 (7), 800-805, 2015 | 36 | 2015 |